News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Howe Jill Ann
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Howe Jill Ann (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Granted 12,500 shares
@ $0
Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
| 03/10/2023 |
4
| Howe Jill Ann (CFO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.46, valued at
$219k
|
|
| 01/05/2023 |
4
| Howe Jill Ann (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 19 shares
@ $0 |
|
| 11/16/2022 |
4
| Howe Jill Ann (CFO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $1.36, valued at
$1.4M
|
|
| 11/16/2022 |
3
| Howe Jill Ann (CFO) has filed a Form 3 on Lineage Cell Therapeutics, Inc. |
| 06/17/2022 |
4
| Howe Jill Ann (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Granted 96,154 shares
@ $0
Granted 148,810 options to buy
@ $0.64, valued at
$95.2k
|
|
| 11/05/2021 |
4
| Howe Jill Ann (Director) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 76,754 shares
@ $0
Granted 82,879 options to buy
@ $3.11, valued at
$257.8k
|
|
| 11/05/2021 |
3
| Howe Jill Ann (Director) has filed a Form 3 on PROGENITY, INC. |
|
|